Co. Stehman-breen et al., Racial differences in bone mineral density and bone loss among end-stage renal disease patients, AM J KIDNEY, 33(5), 1999, pp. 941-946
Although black patients without end-stage renal disease (ESRD) have a great
er bone mineral density (BMD) than whites, the impact of race on BMD among
patients with ESRD who are likely to have varying degrees of renal osteodys
trophy is not known. We undertook a cohort study of 106 hemodialysis patien
ts comparing BMD and bone loss between black and white patients with ESRD t
o determine if black patients have a greater BMD and less bone loss than wh
ite patients with ESRD. BMD was determined by dual-energy radiograph absorp
tiometry (DEXA). Osteopenia was defined as greater than 1 standard deviatio
n (SD) less than the mean of peak bone mass (T score < -1), and osteoporosi
s was defined as greater than 2.5 SDs less than the mean of peak bone mass
(T score < -2.5). The association between BMD and race was estimated using
linear regression. The risk for osteopenia among black compared with white
patients was calculated using logistic regression. Black patients were simi
lar to white patients with respect to all characteristics noted, except bla
ck patients were less likely to be men (69.7% v 49.4%) and tended to have g
reater intact parathyroid hormone (PTH) values (mean, 403.2 +/- 384.5 pg/mL
v 161.4 +/- 129.0 pg/mL), Compared with whites, the BMD of blacks was a me
an of 1.15 (95% confidence interval [CI], 0.54 to 1.78) SDs greater at the
femoral neck after adjusting for age, PTH level, and sex. The percentage of
bone loss per year was similar between blacks and whites. The risk for ost
eopenia among blacks was significantly less than that among whites (odds ra
tio = 0.15; 95% CI, 0.04 to 0.59) after adjusting for age, sex, and PTH lev
el. Black patients with ESRD have a greater BMD and are at decreased risk f
or osteopenia compared with whites, independent of renal osteodystrophy. Wh
en considering bone disease among patients with ESRD, physicians should als
o consider osteoporosis acid the impact of race on BMD. (C) 1999 by the Nat
ional Kidney Foundation, Inc.